Maxell Ltd. will invest approximately 5 billion yen to strengthen the production facilities and expand the building at Ono Works to increase the production capacity of primary batteries for medical devices. The goal is to double the current production capacity^*1 of primary batteries for medical devices by the end of FY2027.

Specifically, the Ono Works started operations in 1992. Mainly, it produces primary batteries such as alkaline button batteries, silver oxide batteries, and lithium coin cell batteries. These batteries are used in small medical devices such as continuous glucose monitoring (CGM^*2) and capsule endoscopes. Primarily, the demand for primary batteries for medical devices is expected to continue to grow in the global market. Also, higher-quality products are required. Maxell’s primary batteries achieve high reliability that is required for medical device batteries through its cultivated sealing technology and long-life technology.

Specifically, this investment is part of a growth investment of approximately ¥35 billion during the period of the medium-term management plan MEX26 announced on June 5, 2024. Maxell will continue to contribute to the development of society by providing highly reliable batteries that meet diverse needs from the Ono Plant, which is a technology development and production base for primary batteries.

^*1 Approximately double the current production capacity of Maxell’s primary batteries for medical devices as of July 2024.

^*2 CGM：Continuous Glucose Monitoring

This is an online translation of a Japanese press release with slight editing made by Dempa.

-16 September 2024-